Cargando…

Mer or Axl Receptor Tyrosine Kinase Inhibition Promotes Apoptosis, Blocks Growth, and Enhances Chemosensitivity of Human Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is a prevalent and devastating disease that claims more lives than breast, prostate, colon, and pancreatic cancers combined. Current research suggests that standard chemotherapy regimens have been optimized to maximal efficiency. Promising new treatment strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linger, Rachel M.A., Cohen, Rebecca A., Cummings, Christopher T., Sather, Susan, Migdall-Wilson, Justine, Middleton, Deryck H.G., Lu, Xian, Barón, Anna E., Franklin, Wilbur A., Merrick, Daniel T., Jedlicka, Paul, DeRyckere, Deborah, Heasley, Lynn E., Graham, Douglas K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502700/ https://www.ncbi.nlm.nih.gov/pubmed/22890323 http://dx.doi.org/10.1038/onc.2012.355

Ejemplares similares

Mer590, a novel monoclonal antibody targeting MER receptor tyrosine kinase, decreases colony formation and increases chemosensitivity in non-small cell lung cancer
por: Cummings, Christopher T., et al.
Publicado: (2014)

Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus
por: Migdall-Wilson, Justine, et al.
Publicado: (2012)

Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia
por: Brandao, L N, et al.
Publicado: (2013)

Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2013)

Erratum: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia
por: Lee-Sherick, A B, et al.
Publicado: (2016)

Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
por: Yan, Dan, et al.
Publicado: (2021)

Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
por: Schoumacher, Marie, et al.
Publicado: (2017)

The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages
por: Jiménez-García, Lidia, et al.
Publicado: (2022)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma
por: Pontara, Andrea, et al.
Publicado: (2020)

UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
por: Zhang, Weihe, et al.
Publicado: (2014)

Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as Mer and Axl tyrosine kinase inhibitors
por: Chung, Shin Hyuck, et al.
Publicado: (2020)

Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia
por: Lee-Sherick, Alisa B., et al.
Publicado: (2015)

Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers
por: Grabiec, Aleksander M, et al.
Publicado: (2018)

Roles of Sialic Acid, AXL, and MER Receptor Tyrosine Kinases in Mumps Virus Infection of Mouse Sertoli and Leydig Cells
por: Wang, Fei, et al.
Publicado: (2020)

Tyrosine Kinase Receptors Axl and MerTK Mediate the Beneficial Effect of Electroacupuncture in a Cuprizone-Induced Demyelinating Model
por: Zou, Zaofeng, et al.
Publicado: (2020)

Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER
por: Hsu, Jeff, et al.
Publicado: (2023)

The Receptor Tyrosine Kinase AXL in Cancer Progression
por: Rankin, Erinn B., et al.
Publicado: (2016)

Coordinated expression of tyro3, axl, and mer receptors in macrophage ontogeny
por: Malawista, Anna, et al.
Publicado: (2016)

Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer
por: Zagórska, Anna, et al.
Publicado: (2020)

Development of a Spontaneous Liver Disease Resembling Autoimmune Hepatitis in Mice Lacking Tyro3, Axl and Mer Receptor Tyrosine Kinases
por: Qi, Nan, et al.
Publicado: (2013)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto, Ross A, et al.
Publicado: (2015)

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis
por: Pagani, Sara, et al.
Publicado: (2020)

The Current State of FLT3 Inhibition in Acute Myeloid Leukemia – Pitfalls and Promises
por: Minson, Katherine A, et al.
Publicado: (2017)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
por: Uribe, Diana J., et al.
Publicado: (2017)

AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity
por: Schmid, Edward T, et al.
Publicado: (2016)

Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression
por: He, Lirui, et al.
Publicado: (2020)

Axl receptor tyrosine kinase is a regulator of apolipoprotein E
por: Zhao, Wenchen, et al.
Publicado: (2020)

Predicting the Specificity- Determining Positions of Receptor Tyrosine Kinase Axl
por: Karakulak, Tülay, et al.
Publicado: (2021)

The Axl receptor tyrosine kinase is a discriminator of macrophage function in the inflamed lung
por: Fujimori, T, et al.
Publicado: (2015)

Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
por: Myers, Kayla V., et al.
Publicado: (2019)

Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
por: von Mässenhausen, Anne, et al.
Publicado: (2016)

AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
por: Choi, Yun Jung, et al.
Publicado: (2019)

Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene
por: Park, Jeong-Woong, et al.
Publicado: (2017)

Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours
por: Green, J, et al.
Publicado: (2006)

Targeting inflammation in type 2 diabetes by antibody-mediated Tyro-3, Axl, Mer receptor activation
por: Lee, Chien-Hsing, et al.
Publicado: (2015)

Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
por: Brenig, Robert, et al.
Publicado: (2019)

AXL receptor tyrosine kinase modulates gonadotropin-releasing hormone receptor signaling
por: Mohammadzadeh, Pardis, et al.
Publicado: (2023)

Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma
por: Yu, H, et al.
Publicado: (2015)

Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
por: Lauter, Markus, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_blebnjpbcopuf1ngbhhaig0fqb